Use of Peripheral Blood to Measure Residual Disease by Flow Cytometry in Adult Acute Myeloid Leukemia: Final Report of the Prospective GIMEMA AML1310 Trial.
- DOI
- 10.1002/ajh.70490
- Published
- 2026 Sep 1
- Container
- American journal of hematology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/ajh.70490,
title = {Use of Peripheral Blood to Measure Residual Disease by Flow Cytometry in Adult Acute Myeloid Leukemia: Final Report of the Prospective GIMEMA AML1310 Trial.},
author = {Maurillo L and Buccisano F and Palmieri R and Cipriani M and Piciocchi A and Principe MID and Paterno G and Tiribelli M and Martelli MP and Salutari P and Curti A and Fazi P and Consalvo MI and Ottone T and Divona MD and Moretti F and Meddi E and Voso MT and Candoni A and Venditti A},
year = {2026},
journal = {American journal of hematology},
doi = {10.1002/ajh.70490},
url = {https://doi.org/10.1002/ajh.70490}
}RIS
TY - JOUR TI - Use of Peripheral Blood to Measure Residual Disease by Flow Cytometry in Adult Acute Myeloid Leukemia: Final Report of the Prospective GIMEMA AML1310 Trial. AU - Maurillo L AU - Buccisano F AU - Palmieri R AU - Cipriani M AU - Piciocchi A AU - Principe MID AU - Paterno G AU - Tiribelli M AU - Martelli MP AU - Salutari P AU - Curti A AU - Fazi P AU - Consalvo MI AU - Ottone T AU - Divona MD AU - Moretti F AU - Meddi E AU - Voso MT AU - Candoni A AU - Venditti A PY - 2026 JO - American journal of hematology DO - 10.1002/ajh.70490 UR - https://doi.org/10.1002/ajh.70490 ER -
APA
L, M., F, B., R, P., M, C., A, P., MID, P., G, P., M, T., MP, M., P, S., A, C., P, F., MI, C., T, O., MD, D., F, M., E, M., MT, V., A, C., & A, V. (2026). Use of Peripheral Blood to Measure Residual Disease by Flow Cytometry in Adult Acute Myeloid Leukemia: Final Report of the Prospective GIMEMA AML1310 Trial.. American journal of hematology. https://doi.org/10.1002/ajh.70490
Source records
- pubmed · retrieved 2026-09-26T21:37:32.815Z